SFM
SGMO

Sphera Funds Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sphera Funds Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-281,291
Closed -$3.03M – 97
2019
Q2 		$3.03M Buy
+281,291
New +$2.99M 0.41% 61
2019
Q1 		– Sell
-340,000
Closed -$3.9M – 118
2018
Q4 		$3.9M Buy
+340,000
New +$4.22M 0.44% 52
2015
Q2 		– Sell
-140,000
Closed -$2.19M – 151
2015
Q1 		$2.19M Sell
140,000
-60,000
-30% -$928K 0.23% 100
2014
Q4 		$3.04M Buy
+200,000
New +$2.43M 0.52% 62

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sphera Funds Management's SGMO Position: Q3 2019 in Review

Sphera Funds Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2019, closing a stake of 281,291 shares — an estimated $3.03M sold.

Sphera Funds Management first reported a position in SGMO in Q4 2014 and held it in 4 quarters. The position peaked at $3.9M in Q4 2018. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

  • Sphera Funds Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2019 after selling out during the quarter.
  • Sphera Funds Management sold 281,291 SANGAMO THERAPEUTICS INC shares in Q3 2019, an estimated $3.03M.
  • Sphera Funds Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 4 quarters.
  • Sphera Funds Management's SANGAMO THERAPEUTICS INC position peaked at $3.9M in Q4 2018.
  • 184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Sphera Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.